Indivior Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 838

Employees

  • Latest Deal Type
  • Debt - Merger

  • Financing Rounds
  • 13

  • Investments
  • 4

Indivior General Information

Description

Developer of pharmaceutical drugs focused on developing medicines to treat substance use disorders and serious mental illnesses. The company specializes in long-acting injectable medications, sublingual films, opioid use disorder treatments, buprenorphine extended-release injections, buprenorphine and naloxone films, and opioid overdose reversal products, providing healthcare systems in the United States and international markets with evidence-based pharmacotherapies to support long-term patient recovery.

Contact Information

Website
www.indivior.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 10710 Midlothian Turnpike
  • Suite 125
  • North Chesterfield, VA 23235
  • United States
+1 (804)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Supernus
Vertical(s)
Life Sciences
Corporate Office
  • 10710 Midlothian Turnpike
  • Suite 125
  • North Chesterfield, VA 23235
  • United States
+1 (804)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Indivior Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Indivior‘s full profile, request access.

Request a free trial

Indivior Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical drugs focused on developing medicines to treat substance use disorders and serious mental il
Drug Discovery
North Chesterfield, VA
838 As of 2025

Lund, Sweden
 

Palo Alto, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Indivior Competitors (42)

One of Indivior’s 42 competitors is Camurus, a Corporation company based in Lund, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Camurus Corporation Lund, Sweden
SCILEX Holding Formerly VC-backed Palo Alto, CA
Ethypharm Private Equity-Backed Saint Cloud, France
Alvogen Group Formerly PE-Backed Morristown, NJ
ARS Pharmaceuticals Formerly VC-backed San Diego, CA
You’re viewing 5 of 42 competitors. Get the full list »

Indivior Patents

  • 398

    Total Documents Applications and Grants

  • Total Patents Families

  • 235

    Granted

  • 20

    Pending

  • Expiring in next 12 mo

Indivior Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260306480-A1 Rapid induction with monthly injectable buprenorphine extended-release Pending 04-Apr-2025
US-20260306481-A1 Rapid induction with monthly injectable buprenorphine extended-release Pending 04-Apr-2025
US-20260256774-A1 Methods of treating opioid overdose to prevent or reduce the risk of adverse health effects resulting from an opioid overdose Pending 03-Mar-2025
US-20250255861-A1 Methods for administering buprenorphine Pending 31-Oct-2023
AU-2024364754-A1 Rapid induction with monthly injectable buprenorphine extended-release Pending 18-Oct-2023 A61K31/4355
To view Indivior’s complete patent history, request access »

Indivior Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Indivior Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Indivior‘s full profile, request access.

Request a free trial

Indivior Investments & Acquisitions (4)

Indivior’s most recent deal was a Later Stage VC with Lassen Peak for . The deal was made on 05-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lassen Peak 05-Jan-2026 Later Stage VC Electronic Equipment and Instruments
Sagent Pharmaceuticals (Pharmaceutical Production Facility in Raleigh) 01-Nov-2023 Corporate Asset Purchase Buildings and Property
C4X Discovery Holdings (C4X_3256 (INDV-2000)) 31-Jul-2023 Corporate Asset Purchase Buildings and Property
Opiant Pharmaceuticals 02-Mar-2023 Merger/Acquisition Pharmaceuticals
To view Indivior’s complete investments and acquisitions history, request access »

Indivior FAQs

  • When was Indivior founded?

    Indivior was founded in 2014.

  • Where is Indivior headquartered?

    Indivior is headquartered in North Chesterfield, VA.

  • What is the size of Indivior?

    Indivior has 838 total employees.

  • What industry is Indivior in?

    Indivior’s primary industry is Drug Discovery.

  • Is Indivior a private or public company?

    Indivior is a Private company.

  • What is Indivior’s current revenue?

    The current revenue for Indivior is .

  • How much funding has Indivior raised over time?

    Indivior has raised $650M.

  • Who are Indivior’s investors?

    JAB Holding Company, Oaktree Capital Management, and Reckitt Benckiser Group have invested in Indivior.

  • Who are Indivior’s competitors?

    Camurus, SCILEX Holding, Ethypharm, Alvogen Group, and ARS Pharmaceuticals are some of the 42 competitors of Indivior.

  • When was Indivior acquired?

    Indivior was acquired on 02-Nov-2026.

  • Who acquired Indivior?

    Indivior was acquired by Supernus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process